Stock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses

Stock Track

02/26

Collegium Pharmaceutical's stock plummeted 8.74% during intraday trading on Thursday, following the release of its fourth-quarter financial results.

The biopharmaceutical company reported adjusted earnings per share of $2.04 for the quarter, which missed the analyst consensus estimate of $2.33 by 12.37%. Quarterly revenue came in at $205.4 million, a 13% year-over-year increase but slightly below the estimate of $206.4 million.

Despite the company reaffirming its full-year 2026 guidance and reporting strong growth in its Jornay PM product, the double miss on both earnings and revenue targets appears to have driven investor disappointment and the sharp sell-off.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1198809733"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198809733\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198809733?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 23:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198809733","market":"sg","top_or_hot":-1,"title":"Stock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses","media":"Stock Track","content":"<p>Collegium Pharmaceutical's stock plummeted 8.74% during intraday trading on Thursday, following the release of its fourth-quarter financial results.</p><p>The biopharmaceutical company reported adjusted earnings per share of $2.04 for the quarter, which missed the analyst consensus estimate of $2.33 by 12.37%. Quarterly revenue came in at $205.4 million, a 13% year-over-year increase but slightly below the estimate of $206.4 million.</p><p>Despite the company reaffirming its full-year 2026 guidance and reporting strong growth in its Jornay PM product, the double miss on both earnings and revenue targets appears to have driven investor disappointment and the sharp sell-off.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 23:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Collegium Pharmaceutical's stock plummeted 8.74% during intraday trading on Thursday, following the release of its fourth-quarter financial results.</p><p>The biopharmaceutical company reported adjusted earnings per share of $2.04 for the quarter, which missed the analyst consensus estimate of $2.33 by 12.37%. Quarterly revenue came in at $205.4 million, a 13% year-over-year increase but slightly below the estimate of $206.4 million.</p><p>Despite the company reaffirming its full-year 2026 guidance and reporting strong growth in its Jornay PM product, the double miss on both earnings and revenue targets appears to have driven investor disappointment and the sharp sell-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COLL","symbol_name":"Collegium Pharmaceutical, Inc.","start_time":0,"source_url":"","article_id":"1198809733","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198809733","pubTimestamp":1772118785,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Collegium Pharmaceutical's stock plummeted 8.74% during intraday trading on Thursday, following the release of its fourth-quarter financial results.The biopharmaceutical company reported adjusted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COLL":"Collegium Pharmaceutical, Inc."},"translate_title":"个股追踪|Collegium Pharmaceutical盘中暴跌8.74%因Q4盈利营收不及","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COLL":1},"content_text":"Collegium Pharmaceutical's stock plummeted 8.74% during intraday trading on Thursday, following the release of its fourth-quarter financial results.The biopharmaceutical company reported adjusted earnings per share of $2.04 for the quarter, which missed the analyst consensus estimate of $2.33 by 12.37%. Quarterly revenue came in at $205.4 million, a 13% year-over-year increase but slightly below the estimate of $206.4 million.Despite the company reaffirming its full-year 2026 guidance and reporting strong growth in its Jornay PM product, the double miss on both earnings and revenue targets appears to have driven investor disappointment and the sharp sell-off.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}